Toxicity of nanoparticles seminar
Posted by Peter Ehrhard
Dr. Yongbin Zhang of the U.S. Food and Drug Administration (FDA) will give a seminar at 3 p.m. Monday, Oct. 27, in Room 139 Schrenk Hall. The title of his presentation will be “Characterizations in Nanotoxicity Assessment and Nanomedicine Development: A Regulatory Perspective.” Zhang evaluates neurotoxicity and particle-kinetics of engineered nanomaterials in-vitro and in-vivo. He is a member of the FDA’s Nanotechnology Core Facility and established the first laboratory to develop and conduct nanotoxicology research for the FDA in 2011. He has received numerous awards, including an FDA Outstanding Junior Investigator Award in Nanotoxicology Research and a FDA Outstanding Service Award.
Posted by Peter Ehrhard
